Invention Grant
- Patent Title: Method for diagnosing multiple sclerosis
- Patent Title (中): 诊断多发性硬化症的方法
-
Application No.: US12556296Application Date: 2009-09-09
-
Publication No.: US08216791B2Publication Date: 2012-07-10
- Inventor: Nir Dotan , Avinoam Dukler
- Applicant: Nir Dotan , Avinoam Dukler
- Applicant Address: IL Modi'in
- Assignee: Glycominds Ltd.
- Current Assignee: Glycominds Ltd.
- Current Assignee Address: IL Modi'in
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Agent Ivor R. Elrifi; Ingrid A. Beattie
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
Disclosed is a method for diagnosing and prognosing multiple sclerosis and more particularly to a method for diagnosing and prognosing multiple sclerosis by measuring levels of antibodies. The levels of IgM-type anti-Glc(α1,2)Glc(α) or Glc(α1,3)Glc(α) or Glc(α1,6)Glc(α) antibodies in serum act as diagnostic markers for MS disease and as prognostic biomarkers for the conversion of CIS patients suggestive of MS to clinically definite MS (CDMS) within 24 months.
Public/Granted literature
- US20100159472A1 Method for Diagnosing Multiple Sclerosis Public/Granted day:2010-06-24
Information query
IPC分类:
